Company
United StatesPublic company, NASDAQ: AXGNAxogen Corp (NASDAQ: AXGN), Vandalia, OH – FDA Inspections
Inspection records and compliance data for Axogen Corp in Vandalia, Ohio. 2 FDA inspections on record, 1 Form 483, last inspected April 29, 2025. Publicly traded as NASDAQ: AXGN.
Company Profile
This profile covers Axogen Corp based in Vandalia, Ohio, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected September 6, 2024. Last inspected April 29, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 29, 2025 | Not classified | Biologics | 1277592 |
| September 6, 2024 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1249756 |
FDA documents
Form 483s (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Axogen Corp
Stock ticker
AXGN
Exchange
NASDAQ
Share price
$55.40
Market cap
$3.3B
Price as of
November 13, 2026
FEI Number
3023488176
Address
913 Industrial Park Dr, Vandalia, Ohio 45377, United States
Country
United States
ID: 8b9c1a0d-6561-4eab-baf7-cc2fa49dfb30